SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-001122
Filing Date
2018-07-18
Accepted
2018-07-18 11:57:46
Documents
2
Period of Report
2018-07-12

Document Format Files

Seq Description Document Type Size
1 form4-07182018_080729.html 4  
1 form4-07182018_080729.xml 4 5670
2 ex24-07182018_080731.htm EX-24 6783
  Complete submission text file 0001415889-18-001122.txt   13903
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O AZURRX BIOPHARMA, INC. 760 PARKSIDE AVE. SUITE 217 BROOKLYN NY 11226
Business Address
Dupret Daniel (Reporting) CIK: 0001680916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 18957989